Fractyl Health, Inc. SEC filings GUTS
Fractyl Health, Inc. has 227 filings in SEC EDGAR's recent list, going back to Mar 21, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jan 13, 2026 | — |
| 424B5 | Prospectus supplement | Sep 26, 2025 | — |
| 424B5 | Prospectus supplement | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Aug 5, 2025 | — |
| S-3/A | Filing | Mar 13, 2025 | — |
| S-3 | Shelf registration | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 6, 2024 | — |
| 424B4 | Prospectus | Feb 2, 2024 | — |
| S-1/A | Amended registration statement | Jan 29, 2024 | — |
| S-1 | Registration statement | Dec 14, 2023 | — |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GUTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1572616
- Former names
- Fractyl Laboratories Inc. (until Mar 19, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.